Your browser doesn't support javascript.
loading
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer.
Karunamuni, Roshan A; Huynh-Le, Minh-Phuong; Fan, Chun C; Thompson, Wesley; Eeles, Rosalind A; Kote-Jarai, Zsofia; Muir, Kenneth; Lophatananon, Artitaya; Schleutker, Johanna; Pashayan, Nora; Batra, Jyotsna; Grönberg, Henrik; Walsh, Eleanor I; Turner, Emma L; Lane, Athene; Martin, Richard M; Neal, David E; Donovan, Jenny L; Hamdy, Freddie C; Nordestgaard, Børge G; Tangen, Catherine M; MacInnis, Robert J; Wolk, Alicja; Albanes, Demetrius; Haiman, Christopher A; Travis, Ruth C; Stanford, Janet L; Mucci, Lorelei A; West, Catharine M L; Nielsen, Sune F; Kibel, Adam S; Wiklund, Fredrik; Cussenot, Olivier; Berndt, Sonja I; Koutros, Stella; Sørensen, Karina Dalsgaard; Cybulski, Cezary; Grindedal, Eli Marie; Park, Jong Y; Ingles, Sue A; Maier, Christiane; Hamilton, Robert J; Rosenstein, Barry S; Vega, Ana; Kogevinas, Manolis; Penney, Kathryn L; Teixeira, Manuel R; Brenner, Hermann; John, Esther M; Kaneva, Radka.
Afiliação
  • Karunamuni RA; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA. rakarunamuni@health.ucsd.edu.
  • Huynh-Le MP; Radiation Oncology, George Washington University, Washington, DC, USA.
  • Fan CC; Center for Human Development, University of California San Diego, La Jolla, CA, USA.
  • Thompson W; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA.
  • Eeles RA; The Institute of Cancer Research, London, SM2 5NG, UK.
  • Kote-Jarai Z; Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
  • Muir K; The Institute of Cancer Research, London, SM2 5NG, UK.
  • Lophatananon A; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
  • Schleutker J; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
  • Batra J; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Grönberg H; Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
  • Walsh EI; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK.
  • Turner EL; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, 4059, Australia.
  • Lane A; Translational Research Institute, Brisbane, QLD, 4102, Australia.
  • Neal DE; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  • Donovan JL; Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK.
  • Hamdy FC; Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK.
  • Nordestgaard BG; Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK.
  • Tangen CM; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • MacInnis RJ; Bristol Medical School, Department of Population Health Sciences, University of Bristol, Bristol, UK.
  • Wolk A; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Albanes D; National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, UK.
  • Haiman CA; Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK.
  • Travis RC; Department of Oncology, University of Cambridge, Box 279, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
  • Stanford JL; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
  • Mucci LA; School of Social and Community Medicine, University of Bristol, Bristol, UK.
  • West CML; Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK.
  • Nielsen SF; Faculty of Medical Science, University of Oxford, John Radcliffe Hospital, Oxford, UK.
  • Kibel AS; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Wiklund F; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark.
  • Cussenot O; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Berndt SI; Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.
  • Koutros S; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Grattan Street, Parkville, VIC, 3010, Australia.
  • Sørensen KD; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
  • Cybulski C; Department of Surgical Sciences, Uppsala University, 75185, Uppsala, Sweden.
  • Grindedal EM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
  • Park JY; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA.
  • Ingles SA; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  • Maier C; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.
  • Hamilton RJ; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, 98195, USA.
  • Rosenstein BS; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Vega A; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, M13 9PL, UK.
  • Kogevinas M; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark.
  • Penney KL; Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA, 02115, USA.
  • Teixeira MR; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  • Brenner H; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-75020, Paris, France.
  • John EM; CeRePP, Tenon Hospital, F-75020, Paris, France.
  • Kaneva R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
Prostate Cancer Prostatic Dis ; 24(2): 532-541, 2021 06.
Article em En | MEDLINE | ID: mdl-33420416
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Modelos Estatísticos / Medição de Risco / Polimorfismo de Nucleotídeo Único Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Modelos Estatísticos / Medição de Risco / Polimorfismo de Nucleotídeo Único Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article